60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...
Gene Therapy Market to Hit USD 36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™.
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...
DelveInsight Business Research, LLP: Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...
BioPharma Dive3d
GSK’s 5-in-1 meningococcal shot wins FDA approval
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Eupraxia Pharmaceuticals announces CFO succession
Eupraxia Pharmaceuticals (EPRX)announced that it has appointed Alex Rothwell as the Company’s new Chief Financial Officer, effective ...
Amity University Rajasthan Successfully Concludes E-SUMMIT 2025: A Grand Celebration of Innovation and Entrepreneurship
Amity University Rajasthan successfully hosted E-SUMMIT 2025, a three-day mega event dedicated to fostering innovation, ...